Your browser doesn't support javascript.
loading
Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?
Chan, Noel; Sager, Philip T; Lawrence, Jack; Ortel, Thomas's; Reilly, Paul; Berkowitz, Scott; Kubitza, Dagmar; Eikelboom, John; Florian, Jeffry; Stockbridge, Norman; Rose, Martin; Temple, Robert; Seltzer, Jonathan H.
Afiliação
  • Chan N; McMaster University, Hamilton, Ontario, Canada. Electronic address: Noel.Chan@monashhealth.org.
  • Sager PT; Stanford University, Palo Alto, CA.
  • Lawrence J; Bristol Myers Squibb, Princeton, NJ.
  • Ortel T; Duke University, Durham, NC.
  • Reilly P; Boehringer Ingleheim, Ridgefield, CT.
  • Berkowitz S; Bayer, Parsippany, NJ.
  • Kubitza D; Bayer AG, Wuppertal, Germany.
  • Eikelboom J; McMaster University, Hamilton, Ontario, Canada.
  • Florian J; Food and Drug Administration, Silver Spring, MD.
  • Stockbridge N; Food and Drug Administration, Silver Spring, MD.
  • Rose M; Food and Drug Administration, Silver Spring, MD.
  • Temple R; Food and Drug Administration, Silver Spring, MD.
  • Seltzer JH; ACI Clinical, Bala Cynwyd, PA.
Am Heart J ; 199: 59-67, 2018 05.
Article em En | MEDLINE | ID: mdl-29754667

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Anticoagulantes Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Anticoagulantes Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2018 Tipo de documento: Article